Romano Brothers & Co’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.1M Sell
123,458
-2,268
-2% -$488K 3.12% 2
2026
Q1
$27.3M Sell
125,726
-442
-0.4% -$98K 3.11% 2
2025
Q4
$28.8M Sell
126,168
-1,958
-2% -$446K 3.28% 2
2025
Q3
$29.7M Buy
128,126
+1,382
+1% +$281K 3.39% 1
2025
Q2
$23.5M Sell
126,744
-3,186
-2% -$592K 2.91% 3
2025
Q1
$27.2M Sell
129,930
-1,251
-1% -$243K 3.52% 1
2024
Q4
$23.3M Sell
131,181
-946
-0.7% -$174K 2.94% 4
2024
Q3
$26.1M Buy
132,127
+1,853
+1% +$346K 3.25% 1
2024
Q2
$22.3M Sell
130,274
-2,460
-2% -$407K 3.09% 2
2024
Q1
$24.2M Sell
132,734
-758
-0.6% -$131K 3.31% 1
2023
Q4
$20.7M Sell
133,492
-943
-0.7% -$137K 3.08% 2
2023
Q3
$20M Buy
134,435
+7,997
+6% +$1.17M 3.12% 2
2023
Q2
$17M Buy
126,438
+89
+0.1% +$13.1K 2.54% 3
2023
Q1
$20.1M Buy
126,349
+2,189
+2% +$335K 3.1% 2
2022
Q4
$20.1M Sell
124,160
-2,858
-2% -$438K 3.05% 1
2022
Q3
$17.1M Buy
+127,018
New +$18.2M 2.75% 3

Other funds holding ABBV

Romano Brothers & Co's ABBV Position: Q2 2026 in Review

Romano Brothers & Co reduced its AbbVie (ABBV) stake by 1.8% in Q2 2026, selling an estimated $488K and leaving 123,458 shares worth $31.1M. The position accounts for 3.12% of the portfolio, ranked #2.

Romano Brothers & Co first reported a position in ABBV in Q3 2022 and has held it in 16 quarters since. 1,993 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Romano Brothers & Co held 123,458 shares of AbbVie worth $31.1M as of Q2 2026.
  • Romano Brothers & Co sold 2,268 AbbVie shares in Q2 2026, an estimated $488K.
  • AbbVie made up 3.12% of Romano Brothers & Co's portfolio in Q2 2026, its #2 holding.
  • Romano Brothers & Co first reported a position in AbbVie in Q3 2022 and has held it in 16 quarters since.
  • 1,993 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Romano Brothers & Co's 13F filing for Q2 2026, filed 22 Jul 2026.